Bupivacaine Hydrochloride from China
Bupivacaine hydrochloride is an amide-type local anesthetic with an acyclic carboxamide group, supplied as its hydrochloride salt. Under HTS 2924.19.80.00, the salt classifies with the parent acyclic amide per chapter note 3(C)(1), covering 'other' derivatives.
Duty Rate — China → United States
31.5%
Rate breakdown
9903.88.0325%Except as provided in headings 9903.88.13, 9903.88.18, 9903.88.33, 9903.88.34, 9903.88.35, 9903.88.36, 9903.88.37, 9903.88.38, 9903.88.40, 9903.88.41, 9903.88.43, 9903.88.45, 9903.88.46, 9903.88.48, 9903.88.56, 9903.88.64, 9903.88.66, 9903.88.67, 9903.88.68, or 9903.88.69, articles the product of China, as provided for in U.S. note 20(e) to this subchapter and as provided for in the subheadings enumerated in U.S. note 20(f)
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Submit salt composition analysis showing equivalence to parent amide for tariff purposes
• Comply with 21 CFR import alerts for anesthetics and maintain cold chain documentation
• Prevent reclassification by specifying pharmaceutical end-use, avoiding bulk chemical headings